title: Putting oncology patients at risk.
abstract: Using genomic tests to personalize oncology treatment is a worthy endeavor. But when the rush to capitalize on biomedical research overcomes the rules of evidence, it's the patients who suffer.
authors.forename: Bob
authors.initials: B
authors.lastname: Carlson